Literature DB >> 29312665

Association of epithelial-to-mesenchymal transition circulating tumor cells in non-small cell lung cancer (NSCLC) molecular subgroups.

Ippokratis Messaritakis1, Athanasios Kotsakis1,2, Vassilis Georgoulias2.   

Abstract

Entities:  

Year:  2017        PMID： 29312665      PMCID： PMC5757021          DOI： 10.21037/jtd.2017.11.106

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Authors:  Anurag Singh; Patricia Greninger; Daniel Rhodes; Louise Koopman; Sheila Violette; Nabeel Bardeesy; Jeff Settleman
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

2.  Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Authors:  Paola Ulivi; Elisa Chiadini; Claudio Dazzi; Alessandra Dubini; Matteo Costantini; Laura Medri; Maurizio Puccetti; Laura Capelli; Daniele Calistri; Alberto Verlicchi; Alessandro Gamboni; Maximilian Papi; Marita Mariotti; Nicoletta De Luigi; Emanuela Scarpi; Sara Bravaccini; Gian Michele Turolla; Dino Amadori; Lucio Crinò; Angelo Delmonte
Journal:  Clin Lung Cancer       Date:  2015-12-01       Impact factor: 4.785

Review 3.  Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity.

Authors:  Alexios Matikas; Dimitrios Mistriotis; Vasilios Georgoulias; Athanasios Kotsakis
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-09       Impact factor: 6.312

Review 4.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

Authors:  Jason J Christiansen; Ayyappan K Rajasekaran
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

5.  Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors:  Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

Review 6.  Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Authors:  Nikolas H Stoecklein; Christoph A Klein
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

7.  Recent advances in the molecular characterization of circulating tumor cells.

Authors:  Lori E Lowes; Alison L Allan
Journal:  Cancers (Basel)       Date:  2014-03-13       Impact factor: 6.639

Review 8.  Emerging concepts in liquid biopsies.

Authors:  Samantha Perakis; Michael R Speicher
Journal:  BMC Med       Date:  2017-04-06       Impact factor: 8.775

9.  Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.

Authors:  Catherine Wilson; Katrina Nicholes; Daisy Bustos; Eva Lin; Qinghua Song; Jean-Philippe Stephan; Donald S Kirkpatrick; Jeff Settleman
Journal:  Oncotarget       Date:  2014-09-15

10.  Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.

Authors:  Claudia Voena; Lydia M Varesio; Liye Zhang; Matteo Menotti; Teresa Poggio; Elena Panizza; Qi Wang; Valerio G Minero; Sharmila Fagoonee; Mara Compagno; Fiorella Altruda; Stefano Monti; Roberto Chiarle
Journal:  Oncotarget       Date:  2016-05-31
View more
  2 in total

1.  Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients.

Authors:  Spyridoula D Katsarou; Ippokratis Messaritakis; Anastasia Voumvouraki; Stavros Kakavogiannis; Athanasios Κotsakis; Saad Alkahtani; Christos Stournaras; Stuart S Martin; Vassilis Georgoulias; Galatea Kallergi
Journal:  J Pers Med       Date:  2022-01-25

2.  Activation of the Hedgehog pathway mediates resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer.

Authors:  Hualin Chen; Donghong Yang; Yongcun Wang; Hua Tao; Yiping Luo; Aibing Wu; Shujun Li; Zhixiong Yang; Ming Chen
Journal:  J Cancer       Date:  2022-01-04       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.